TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
TCL Archive NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines November 26, 1993
TCL Archive In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott May 11, 1990
